Impel Pharmaceuticals Inc (IMPL) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access IMPL Annual Balance Sheets →
A period-by-period view of the balance sheet from Impel Pharmaceuticals Inc to Sep 30 2022 helps clarify how Sep 30 2023's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2023)
(Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022)
Assets
Cash & cash equivalent0.24
Cash & Short-term Investments0.00
Accounts receivable6.59
Inventories6.86
Other Current Assets4.50
Prepaid Expense And Other Assets Current5.24
Total Current Assets23.43
Equipment/Property/Plant Net4.09
Other Assets, Noncurrent5.00
Restricted Cash4.50
Operating Lease Right Of Use Asset3.73
Total Assets35.07
Liabilities
Accounts Payable, Current AC3.73
Accrued Liabilities And Other Liabilities8.45
Long-term Debt, Current Maturities LO111.00
Other Liabilities, Current1.56
Total Current Liabilities124.74
Long-term debt0.00
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.00
Other liabilities, Noncurrent2.24
Deferred Royalty Obligation Current0.00
Operating Lease Liability Current1.56
Common Stock Warrant Liabilities0.00
Operating Lease Liability Noncurrent2.24
Deferred Royalty Obligation Non Current0.00
Total Liabilities126.98
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock280.42
Retained Earnings / Accumulated Deficit-372.35
Other Equity0.00
Common Stockholder's Equity-91.91
Total Stockholder's Equity-91.91
Liabilities & Stockholder's Equity35.07
4 historic quarters locked

Sign in to unlock the full Impel Pharmaceuticals Inc balance sheet history.

About Impel Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-23-063759

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.